Signal Advisors Wealth’s AstraZeneca AZN Stock Holding History

Signal Advisors Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513K	Buy	2,706 +245	+10%	+$46.1K	0.03%	414
2026 Q1	$485K	Sell	2,461 -517	-17%	-$99.7K	0.03%	370
2025 Q4	$548K	Sell	2,978 -105	-3%	-$18.4K	0.04%	292
2025 Q3	$473K	Buy	+3,083	New	+$467K	0.04%	281

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Signal Advisors Wealth's AZN Position: Q2 2026 in Review

Signal Advisors Wealth increased its AstraZeneca (AZN) stake by 10% in Q2 2026, buying an estimated $46.1K and bringing the position to 2,706 shares worth $513K. The position accounts for 0.03% of the portfolio, ranked #414.

Signal Advisors Wealth first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $548K in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Signal Advisors Wealth held 2,706 shares of AstraZeneca worth $513K as of Q2 2026.
Signal Advisors Wealth bought 245 AstraZeneca shares in Q2 2026, an estimated $46.1K.
AstraZeneca made up 0.03% of Signal Advisors Wealth's portfolio in Q2 2026, its #414 holding.
Signal Advisors Wealth first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
Signal Advisors Wealth's AstraZeneca position peaked at $548K in Q4 2025.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.